Study of Eye Movements (EYE) as Early Markers of Brain Dysfunction (BRAIN) in Parkinson's Disease (PARK)

Not Applicable

• Conditions: Parkinson Disease

• Registration Number: NCT04212637
• Lead Sponsor: University Hospital, Grenoble

Brief Summary

Identify the neural bases of eye movements during visual tasks and their dysfunction at early stages of Parkinson disease (de novo).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-10-30
• Study First Submitted QC: 2019-12-26
• Study First Posted: 2019-12-27
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-16
• Last Update Posted: 2020-11-17
• Study Start: 2021-01
• Primary Completion: 2021-12
• Study Completion: 2022-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
MRI images	1 hour	Functional and anatomical brain volumes

Secondary Outcome Measures

Name	Time	Method
Eye latency	1 hour	latency (milliseconds) of ocular saccades
eye amplitude	1 hour	amplitude (degree) of ocular saccades

Trial Locations

Locations (1)

CHU Grenoble-Alpes; 🇫🇷 Grenoble, France